What is first-pass metabolism and its clinical consequence for oral drugs?

• A. The initial hepatic metabolism after absorption reduces the amount reaching systemic circulation, lowering bioavailability.
• B. The metabolic conversion occurs in the kidneys to active metabolites.
• C. The drug is bypassed by the liver via the portal circulation.
• D. There is an increased half-life due to hepatic storage.

Answer: (A)

First-pass metabolism happens when an oral drug is absorbed from the gut and carried through the portal vein to the liver, where enzymes metabolize a portion of it before it reaches the bloodstream. This processing reduces the amount of unchanged drug that enters systemic circulation, which lowers the bioavailability of the dose given by mouth. Clinically, this means oral medicines can be less effective than expected unless the dose is increased, a larger portion is absorbed, or an alternative route is used to bypass the liver (such as sublingual, transdermal, rectal, or parenteral). It also helps explain why some drugs have highly variable effects between patients due to differences in liver enzyme activity or drug interactions that inhibit or induce those enzymes.